°í´ë±¸·Îº´¿ø, Á¦1ȸ ¡®ÀÏŸ¾Ï°ÁÂ, ¾Ï! À̱âÀÚGuro¡¯¡¦
2023-06-22°í´ë±¸·Îº´¿ø, Ç×¾ÏÁ¦ Á¶Á¦·Îº¿ 'APOTECA Chemo' µµÀÔ¡¦
2023-06-22°í·Á´ë ±¸·Îº´¿ø 'Çõ½ÅÇü ÀÇ»ç°úÇÐÀÚ °øµ¿¿¬±¸»ç¾÷ º´¡¦
2023-06-22°í´ë±¸·Îº´¿ø, 2022³â ¿¬±¸Á߽ɺ´¿ø ½ÉÆ÷Áö¾ö °³ÃÖ_ÀÇ¡¦
2023-06-22°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ±èº´Á¶¡¤¼ÀçÈ« ±³¼ö, '2022 º¸¡¦
2023-06-22¡®ÀÇ·á¿ë VR ÄÜÅÙÃ÷ °³¹ß¡¯ À§ÇÑ MOU ü°á_ Ŭ·¡½ººê¡¦
2022-01-13¾Ï »ýÁ¸ÀÚ °ü¸®
2023-08-10½Å¾à°³¹ß¿¡¼ÀÇ KMEDIhub ¿ªÇÒ ¹× ÀǾàÈÇÐ ±â¼ú¼Ò°³
2023-04-07FDA approved development process of paclitaxel drug delivery system
2022-12-20dentification and isolation of active ingredients from natural products
2022-11-15ÇÕ¼º½Å¾à °³¹ß Ãʱ⿬±¸ ¹× Èĺ¸¹°Áú µµÃâ±îÁö ÇʼöÀûÀÎ °í·Á»çÇ×
2022-09-13New Drug Development Process&Strategy
2022-08-31TUMOR-INFILTRATING LYMPHOCYTE THERAPY IN ADVANCED...
½Å»ó¿øRANDOMIZED TRIAL OF TEPOTINIB PLUS GEFITINIB VERSUS...
½Å»ó¿øOVER-EXPRESSION OF LONG NON-CODING RNA UROTHELIAL ...
±èöȯPREDICTION OF AXILLARY LYMPH NODE METASTASIS IN EARLY-STAGE...
¹Ú°æÈGENOMIC SIGNATURES FROM CLINICAL TUMOR SEQUENCING IN...
¹Ú°æÈPIK3CA MUTATION IS ASSOCIATED WITH POOR RESPONSE TO...
¹Ú°æÈ